Skip to main content

Table 7 Adverse event rates (%)

From: Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison

Adverse events a OLAI RLAI
Weight gain 9.0 6.0
Extra-pyramidal symptoms 15.0 25.0
Tardive dyskinesia 0.0 0.0
Somnolence 7.0 5.0
Sexual dysfunction 3.0 3.0
Post-injection syndrome 2.0 0.0
Suicide 0.0 0.0
  1. aAdverse event rates were taken from [14],[40],[48].